| Intrinsic Valuation of: MEDANTA | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 21 | Market Cap | ₹334B | |||||
| 2021 | - | - (-) | P/E Ratio | 60 | Total Asset | ₹48B | |||||
| 2022 | ₹368M | - (-) | Net Income | ₹5B | Total Debt | ₹3B | |||||
| 2023 | ₹4B | 1010.5% (797.1%) | EBITDA | ₹9B | Total Liab | ₹14B | |||||
| 2024 | ₹3B | -18.4% (-32.4%) | Opr Margin | 20.26 | Debt/Equity | 0.08 | |||||
| 2025 | ₹-242M | -107.2% (-106.5%) | PreTax Margin | 18.50 | BV/Share | 126 | |||||
| 5Y Average FCF | ₹2B | 15.0% (219.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.01% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2026 | ₹3B | MBG Intrinsic Value | ₹184 | ||||||||
| 2027 | ₹3B | ||||||||||
| 2028 | ₹4B | ||||||||||
| 2029 | ₹4B | ||||||||||
| 2030 | ₹4B | ||||||||||
| 2031 | ₹4B | ||||||||||
| Terminal Value | ₹97B | Net Worth/Share | ₹126 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹82B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹2B | ₹304 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹3B | WACC | 6.5% | 286 | 311 | 343 | 384 | 439 | |||
| Equity Value | ₹82B | 7.1% | 253 | 272 | 296 | 325 | 362 | ||||
| Shares Outstanding | 268,698,932 | 7.8% | 227 | 242 | 260 | 281 | 308 | ||||
| 8.4% | 206 | 218 | 232 | 248 | 268 | ||||||
| DCF Intrinsic Value | ₹304 | 9.0% | 188 | 198 | 209 | 222 | 237 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||